SS-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
15 |
58.0 |
% |
5.65 |
21.87 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57283 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
14 |
-6.94 |
null |
0.07 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55692 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
-8.57 |
null |
0.09 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54629 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
16 |
-7.24 |
null |
0.04 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56162 |
522 |
SS-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
42.56 |
% |
4.54 |
13.63 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54845 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
-7.21 |
null |
0.1 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56972 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
18 |
-7.39 |
null |
0.1 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55342 |
522 |
SS-Chr 2BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
0.03 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55755 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
12 |
-8.47 |
null |
0.11 |
0.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54634 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
19 |
0.05 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54733 |
522 |
SS-Chr 2BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
98.21 |
% |
0.74 |
2.78 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56325 |
522 |
SS-Chr 2BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
99.55 |
% |
0.28 |
0.93 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56485 |
522 |
SS-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
10 |
1.67 |
mg/kg |
0.37 |
1.18 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59240 |
526 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
15 |
-6.96 |
null |
0.08 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55684 |
522 |
SS-Chr 2BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
12 |
0.05 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55760 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
15 |
1.35 |
E-7mole |
0.21 |
0.83 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55953 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
10 |
-8.41 |
null |
0.2 |
0.62 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56043 |
522 |
SS-Chr 2BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
0.03 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56250 |
522 |
SS-Chr 2BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
10 |
90.7 |
% |
3.32 |
10.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56330 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
-7.3 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56980 |
522 |
SS-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
7 |
1.54 |
mg/kg |
0.23 |
0.62 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58929 |
526 |
SS-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
11 |
1.73 |
mg/kg |
0.14 |
0.46 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58933 |
526 |
SS-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
11 |
1.2 |
mg/kg |
0.2 |
0.68 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59232 |
526 |
SS-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
15 |
48.4 |
% |
4.84 |
18.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57291 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
14 |
1.35 |
E-7mole |
0.2 |
0.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55961 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
18 |
0.06 |
umol/l |
0.01 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54741 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
-8.76 |
null |
0.1 |
0.36 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56038 |
522 |
SS-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
63.07 |
% |
5.21 |
19.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54837 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
0.04 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54971 |
522 |
SS-Chr 2BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
10 |
0.17 |
10E-7mol/l |
0.14 |
0.43 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56255 |
522 |
SS-Chr 2BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
12 |
98.08 |
% |
0.98 |
3.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56490 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
0.56 |
E-7mole |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56585 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
19 |
-7.37 |
null |
0.05 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55334 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
-7.52 |
null |
0.1 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56170 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
16 |
0.06 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54963 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
0.92 |
E-7mole |
0.33 |
1.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56577 |
522 |